US 10653704
Inhalable formulation
granted A61KA61K31/56A61K9/0075
Quick answer
US patent 10653704 (Inhalable formulation) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Branded Pharmaceutical Products R&D, Inc.
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/56, A61K9/0075, A61K9/008, A61K9/124